-
2022-503126-12-01
5
2024-01-05
Hypoparathyroidism
-
2023-503920-14-00
5
2024-01-02
Non-Small Cell Lung Cancer (NSCLC)
-
2022-501220-14-00
4
2023-10-17
epithelial ovarian, primary peritoneal, or fallopian tube cancer
-
2023-504506-11-00
7
2023-10-09
Advanced Solid Tumors
-
2022-502959-54-00
5
2023-09-26
Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring Ep
-
2022-500544-38-00
5
2023-06-05
Advanced Breast Cancer
-
2024-520006-19-00
6
2021-12-15
Non-muscle invasive bladder cancer
-
2023-508922-83-00
10
2021-03-17
Advanced Non-Small Cell Lung Cancer
-
2025-522542-40-00
5
2026-06-19
Acute Ischemic Stroke
-
2025-521587-35-00
5
2026-06-03
Metastatic colorectal cancer
-
2025-523106-32-00
5
2026-05-25
Obesity or Overweight and Type 2 Diabetes
-
2025-522107-18-00
4
2026-05-19
Locally advanced or metastatic Non-Small Cell Lung Cancer
-
2025-523739-20-00
5
2026-05-14
Hypercholesterolemia
-
2025-523659-73-00
5
2026-05-11
Obesity
-
2025-523104-71-00
5
2026-05-08
Obesity or Overweight Without Type 2 Diabetes
-
2025-522979-29-00
5
2026-04-30
Acute myeloid leukemia
-
2025-520466-22-00
5
2026-04-29
Advanced Platinum-resistant Epithelial Ovarian Cancer
-
2025-523717-29-00
5
2026-04-28
HFpEF or HFmrEF and obesity
-
2024-520444-42-00
5
2026-04-15
Overweight or obesity, and knee osteoarthritis
-
2024-520445-23-00
5
2026-04-15
Overweight or obesity, and knee osteoarthritis
-
2023-509220-17-00
7
2026-04-10
Metastatic solid tumors
-
2024-520101-39-00
5
2026-04-01
TROP2 NMR-positive advanced or metastatic non-squamous non-small cell
-
2024-517490-24-00
4
2026-03-31
Small Cell Lung Cancer
-
2025-523533-25-00
10
2026-03-26
Cancer-associated Cachexia